See All Slides -

Slides

Presentation TCT 2012

"Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis: Implications for Transcatheter Aortic Valve Replacement." Circulation. 2012;125:1005-1013.

Presenter: Sachin Goel

October 24, 2012

Presentation TCT 2012

SFA Intervention: State of the Art Today and in 2020

Presenter: Gary Ansel

October 24, 2012

Presentation TCT 2012

TAVR: Next Generation Devices

Presenter: Josep Rodes-Cabau

October 24, 2012

Presentation TCT 2012

Micardia Update: Surgical and Percutaneous Device Progress

Presenter: Maurice Buchbinder

October 24, 2012

Presentation TCT 2012

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Presenter: Julinda Mehilli

October 24, 2012

Presentation TCT 2012

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

Presenter: Howard Herrmann

October 24, 2012

Presentation TCT 2012

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

Patient Selection for the MitraClip: Clinical vs. Anatomic Considerations, and Diagnosis of "Severe" MR

Presenter: Robert Siegel

October 24, 2012

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

Presentation TCT 2012

Late Complication After Rotational Atherectomy

Presenter: Edouard Benit

October 24, 2012

Advertisement

Slides

"Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis: Implications for Transcatheter Aortic Valve Replacement." Circulation. 2012;125:1005-1013.

SFA Intervention: State of the Art Today and in 2020

TAVR: Next Generation Devices

Micardia Update: Surgical and Percutaneous Device Progress

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Patient Selection for the MitraClip: Clinical vs. Anatomic Considerations, and Diagnosis of "Severe" MR

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Late Complication After Rotational Atherectomy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content